MIZELL STEVEN 4

4 · Merck & Co., Inc. · Filed Feb 2, 2024

Form 4

Period: 2024-02-02

EVP, Human Resources

Transactions

Exercise/Conversion
Common Stock
2024-02-02$70.71/sh+824$58,265→ 42,143.145 total
Exercise/Conversion
Common Stock
2024-02-02$73.73/sh+32,170$2,371,894→ 74,313.145 total
Sale
Common Stock
2024-02-02$126.65/sh−50,694$6,420,349→ 23,619.145 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-02-02−824→ 0 total
Exercise: $70.71From: 2019-10-30Exp: 2028-10-29→ Common Stock (824 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2024-02-02−32,170→ 22,088 total
Exercise: $73.73From: 2022-05-04Exp: 2031-05-03→ Common Stock (32,170 underlying)

Footnotes (3)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.
[F3]The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.

Documents

1 file